The protein corona that forms on nanoparticles in blood completely changes their identity, and we still cannot characterize it in vivo

Within seconds of entering the bloodstream, any nanoparticle becomes coated with a layer of hundreds of different blood proteins — the 'protein corona.' This corona, not the engineered surface, is what cells, tissues, and the immune system actually see. A nanoparticle designed with a targeting ligand on its surface may have that ligand completely buried under albumin, immunoglobulins, and complement proteins. The corona determines whether the particle is cleared by macrophages, triggers an immune response, or reaches its target. Despite this, the vast majority of nanoparticle studies characterize particles in buffer, not in biological fluids. The gap between in vitro and in vivo corona composition is enormous. Protein coronas formed in actual blood in living animals have fundamentally different compositions from those formed by incubating particles in serum in a test tube. The soft corona — loosely bound proteins that exchange dynamically — is almost impossible to study because conventional separation techniques (centrifugation, size exclusion) strip it away. This means that the biological identity of a nanoparticle in a living patient is essentially unknown. Drug delivery predictions based on in vitro characterization are unreliable, and clinical failures may be driven by corona effects that were never measured. The problem persists because characterizing the corona in situ requires techniques that can probe protein-nanoparticle interactions without perturbing them. Fluorescent tagging changes protein binding behavior. Centrifugation removes the soft corona. In vivo recovery of nanoparticles from blood is technically demanding and yields tiny amounts of material. Recent work on in situ techniques like fluorescence correlation spectroscopy and isothermal titration calorimetry shows promise, but these methods require specialized equipment, are low-throughput, and are not yet standardized. The field is stuck in a measurement gap: the most important biological property of a nanoparticle is the one we are least equipped to measure.